Moolec Science S.A.
Moolec Science S.A. Q3 FY2024 earnings call
May 30, 2024 · fiscal period ended 2024-03
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2024-05-30
Management highlights
- Gaston highlighted Moolec's achievement of USDA-APHIS regulatory approval for Piggy Sooy, a unique soybean platform technology, and its significance in addressing climate change and food security.
- Amit Dhingra discussed progress on the safflower platform, including GLASO being in pre-commercialization stages, trial production of GLASO, and patents granted for SPC2.
- Jose Lopez Lecube presented financial highlights for Q3 2024, including revenue, expense, and cash utilization details.
Segment performance
During Q3 2024, normalized revenues and other income excluding IAS29 increased year-over-year from nil to approximately $1.3 million, driven by the consolidation of the soy protein ingredient business. Normalized costs of goods sold increased from nil to close to $1 million, resulting in a gross margin of around 18%. SG&A and R&D expenses rose to $2.3 million from $1.4 million in Q3 2023. Operational cash flow for the quarter was approximately $2.7 million, and the cash position as of Q3 2024 was approximately $4.3 million.
Guidance
- Piggy Sooy field trials started in May 2024 at three locations, with scaling up of production planned in 2-4 years and commercialization likely in 2027-2028.
- GLASO is expected to hit the market in the first part of the 2025 calendar year.
- YEA1 scale-up is ongoing in partnership with Grupo Insud in Europe, with open channels to regulators for providing information.
Risks
- Regulatory uncertainties related to obtaining approvals from agencies like the FDA.
- Challenges in market adoption of new food ingredients, as building relationships with customers takes time.
- Inflation and currency risks in Argentina, as Moolec has some costs denominated in Argentine pesos.
Q&A highlights
Q: How does Argentina's economic environment impact Moolec?
A: Jose said Moolec has global operations, with revenues in USD and some costs in Argentine pesos. Devaluation and inflation movements affect costs, but costs in pesos are a small part of the overall structure, and gradual devaluation and declining inflation provide some stability.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
May 30, 2024Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.